戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 P=2.4x10(-14)) was 79.7 kb downstream of F5, coagulation factor V.
2                          A point mutation in coagulation factor V (A1691G) is associated with increas
3 ins of intermediate abundance were selected, coagulation factor V, adiponectin, C-reactive protein (C
4 eptides were 17.0, 25.4, 24.2, and 14.0% for coagulation factor V, adiponectin, CRP, and thyroxine bi
5 ing) were 9.2, 110, 120, and 246 pmol/mL for coagulation factor V, adiponectin, CRP, and thyroxine bi
6 man genetic disorder, combined deficiency of coagulation factor V and factor VIII.
7 a type II (CDAII) and combined deficiency of coagulation factors V and VIII (F5F8D) are the 2 known h
8 lopathy characterized by inactivation of the coagulation factors V and VIII and a derepression of the
9 ng disorder associated with plasma levels of coagulation factors V and VIII approximately 5% to 30% o
10                  The discoidin C2 domains of coagulation factors V and VIII are known to interact wit
11 ve bleeding disorder, combined deficiency of coagulation factors V and VIII.
12 cific subset of secreted proteins, including coagulation factors V and VIII.
13 MAD4, INPP5D, and IRAK3; and a disruption of coagulation factors V and VIII.
14                            The activation of coagulation factors V and X by Russell's viper venom (RV
15 eral substrates, namely mucin, pepsin, human coagulation factor V, and erythroid spectrin.
16                                        Blood coagulation factor V circulates as a procofactor with li
17                    These genes include human coagulation factor V (F5), Weel protein tyrosine kinase
18                            A polymorphism in coagulation factor V, factor V Leiden (FVL), is the majo
19   Affected individuals have normal levels of coagulation factor V (FV) activity, but demonstrate inhi
20                                              Coagulation factor V (FV) circulates as an inactive proc
21 c donor splice site in a patient with severe coagulation factor V (FV) deficiency and life-threatenin
22 ion, which endocytoses fluorescently labeled coagulation factor V (FV) from the media into alpha-gran
23                                              Coagulation factor V (FV) is a central regulator of the
24                          Activation of blood coagulation factor V (FV) is a key reaction of hemostasi
25 binase assembly by directly interacting with coagulation factor V (FV), which has been activated by F
26 ed that Gal8 may also interact with platelet coagulation factor V (FV).
27                                          The coagulation factors V (FV) and VIII (FVIII) are importan
28                             The C domains of coagulation factors V (FV) and VIII (FVIII) are structur
29 protein 2) cargo receptor complex transports coagulation factors V (FV) and VIII (FVIII) from the end
30 s soluble coreceptor MCFD2, LMAN1 transports coagulation factors V (FV) and VIII (FVIII).
31 -derived prothrombin activator homologous to coagulation factors V (FV) and Xa (FXa).
32      A genomic target, a region in the human coagulation Factor V gene (226-bp), was subsequently dir
33 ed a higher risk of severe preeclampsia with coagulation factor V gene (proaccelerin, labile factor)
34 gene, the Coagulation Factor II gene and the Coagulation Factor V gene.
35                                              Coagulation factor V is a critical cofactor for the acti
36                In an essential step of blood coagulation, factor V is proteolytically processed by th
37 nt use of HRT and the presence or absence of coagulation factor V Leiden and prothrombin 20210 G-->A
38                          Deficiency of blood coagulation factor V or tissue factor causes the death o
39  of the method to a tryptic digest of bovine coagulation factor V resulted in identification of sulfa
40 single point mutation in the gene coding for coagulation factor V results in a form of factor Va that
41 h tracks with reduced plasma levels of blood coagulation factors V, VII, VIII, IX, X, and XII.
42 two Npn-1 CUB domains and the amino-terminal coagulation factor V/VIII domain (CF V/VIII) are essenti
43 collapse; antibody (YW107.4.87) binds to the coagulation factor V/VIII domains (b1b2) of NRP1 and blo
44 1691A Leiden mutation in the gene coding for coagulation factor V was determined in the PHS group usi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。